Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 114
Selected: 0
NCT IDTitle
NCT00060138Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
NCT04861259A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT00144664Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
NCT04097444CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC
NCT02795767A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
NCT02485483Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants
NCT06371417Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT00144508Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
NCT00467012Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer
NCT06793553Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC
NCT00144586Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP
NCT00492427Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)
NCT03020160A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A
NCT01713842Tocilizumab Effect iN pOlymyalgia Rheumatica
NCT02537379Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
NCT05907980A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
NCT00345761Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
NCT00746317A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
NCT04511845A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
NCT00433693Correction Study of R744 in Renal Anemia Patients on Hemodialysis
NCT05686369A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)
NCT04740931A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
NCT04318275Objective Pain Measurement Using a Wearable Biosensor and a Mobile Platform in Patients With Endometriosis
NCT00491868Clinical Study of R744 to Hemodialysis Patients
NCT00304551A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
NCT05269667A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
NCT00380601PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)
NCT07416526A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
NCT00447915Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis
NCT03157635Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
NCT05679570Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
NCT04501497Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
NCT00210249Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
NCT04649216Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371
NCT02028884Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
NCT02539680Intestinal Phosphate Transporter Expression in CKD Patients
NCT05022927A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma
NCT01041404ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer
NCT05012618A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
NCT05425446Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
NCT00208260Intensified Chemotherapy in CRC After Resection of Liver Metastases
NCT01656525A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients
NCT03726879A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
NCT04209179A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism
NCT00470223Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
NCT00144599Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT01989780Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
NCT07239336Study of DONQ52 in Active Celiac Disease
NCT00144495A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
NCT06497556A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer